Effectiveness of village doctors led cognitive behavioral therapy for COPD patients in a randomized controlled trial Authors: Maowei Zhang, Pan Zhang, Zongmei Dong, Wenhui Zhang, Yanan Liu, Cheng Qiao, Yixuan Wang, Yixue Jiang, Bi Chen, Yong Chen Published: 2025 ABSTRACT Anxiety and depression are two common symptoms among patients with chronic obstructive pulmonary disease (COPD). The aim of this study was to explore the efficacy of group CBT (GCBT) delivered by village doctors for reducing anxiety and depression symptoms and improving quality of life among community-dwelling COPD patients. This community-based cluster randomized controlled trial was conducted from October to November 2023 in Xuzhou city, China, and involved COPD patients from 18 communities. The participants received either CBT plus usual care (UC) or UC only. Village doctors were trained in CBT before the intervention. A total of 443 participants with COPD and comorbid depression and anxiety were included in the analysis, with 223 patients in the control group receiving UC only and 220 patients in the intervention group receiving CBT plus UC. The depression and anxiety scores of the CBT group were lower than those of the UC group at 6 months [depression: (7.87 ± 3.73) vs. (10.20 ± 3.85); anxiety: (8.23 ± 3.60) vs. (10.71 ± 4.01); t = 12.605, 14.419, both P < 0. 001)]. The SGRQ and mMRC scores in the CBT group were lower than those in the UC group at 6 months [(41.78 ± 21.56) vs. (57.47 ± 24.46), (1.55 ± 0.82) vs. (2.32 ± 1.21); t = 17.518, 8.376, all P < 0.001)]. The FEV1 (% pred) was not significantly different between the CBT group and the UC group at 6 months (t = 2.136, P = 0.128). CBT delivered by village doctors was shown to be an effective and practical method for relieving anxiety and depression and improving the quality of life of community-dwelling COPD patients. Introduction Owing to the persistent respiratory symptoms and airflow limitations associated with chronic obstructive pulmonary disease (COPD), dyspnea, chronic cough and/or sputum production, minimal physical activity and gradual decline in lung function, patients experiencing these symptoms are prone to psychological disorders such as anxiety and depression1. Health outcomes are worse in COPD patients with mood disorders than among COPD patients without mood disorders, although the exact mechanism underlying this difference remains unclear2,3. Many studies have suggested that depression and anxiety increase the risk of hospitalization and mortality, reduce quality of life, reduce self-confidence, increase isolation, aggravate dyspnea-related disability, decrease adherence to pharmacological and nonpharmacological treatments, and decrease adherence to pulmonary rehabilitation1–3. The Global Initiative on Chronic Obstructive Pulmonary Disease (GOLD) emphasizes that anxiety and depression assessments are important components of evaluating the health status of COPD patients4. Ensuring that anxiety and depression are recognized and treated effectively among patients with COPD is essential for optimizing outcomes2. It is crucial to educate primary healthcare practitioners about appropriate anxiety and depression management methods, thus enabling these individuals to manage mood disorders while treating patients with COPD.A series of studies confirmed that pharmacological treatments and nonpharmacological interventions could decrease anxiety and depression symptoms and improve quality of life among patients with COPD1,2,5,6. However, due to concerns about antidepressants being addictive and having potential side effects, patients prefer nonpharmacological treatment. Clinical guidelines also advocate nonpharmacological intervention as a first-line treatment for depression and anxiety in subjects with long-term conditions6. Cognitive behavioral therapy (CBT) is a personalized patient-centered psychotherapy approach aimed at teaching patients the skills to change their emotional state and behavior to resolve their current negative thoughts, beliefs, and behaviors7–9. CBT has been widely used for anxiety and depression interventions among patients with COPD8–18. Previous meta-analyses and reviews have shown that CBT can improve depression and anxiety among patients with COPD8,9,17,18. However, many of these studies have relatively small sample sizes10–16. Therefore, high-quality studies with larger numbers of participants are necessary to confirm the potential beneficial effects of CBT-based interventions on COPD-related depression and anxiety9,18. In previous studies, CBT-based interventions to treat anxiety and depression in COPD patients were implemented by professionals from comprehensive hospitals and were limited to inpatient or ward settings in general hospitals10–16 rather than receiving face-to-face psychological interventions from general practitioners in community settings. Unfortunately, the availability of CBT in China is often limited to specialized psychiatric centers and professionals (typically psychologists). Community access to CBT is limited, especially for families living in rural areas distant from specialized psychiatric centers19. However, China has established a comprehensive primary healthcare system with many primary healthcare doctors, reaching 1.73 million in 201520. The government’s financial input to primary healthcare institutions increased from 2.8 billion USD in 2008 to 33.7 billion USD in 201921. Primary healthcare doctors serve on the front line of primary health careand undertake primary healthcare duties, including chronic disease management20,21. Studies have examined the implementation of CBT by trained counselors for the management of depression22 and by trained general practitioners for the management of anxiety and depression in participants with diabetes23. However, it remains unclear whether CBT can be provided by trained village doctors for the management of psychological disorders among COPD patients. Therefore, the aim of the present study was to determine whether village doctors could be trained to deliver CBT interventions to reduce psychological distress and improve quality of life among COPD patients over a 6-month period compared with control treatments in a real-world setting in China. Methods Study design This study was a community-based cluster randomized controlled trial. Patients with stable COPD who completed community registration before July 2023 were selected from 18 communities in Xuzhou city, and enrollment and baseline surveys were completed in September 2023. Interventions were implemented from October to November 2023, and follow-up was completed in April 2024. Xuzhou cityincludes5 rural districts with an agricultural population of 7 million and is located in Jiangsu Province in eastern China. Approximately 170,000 individuals with COPD were registered in 2040 village clinics (an average of 83 subjects per village clinic). To facilitate the intervention, we sampled from village clinics, rather than individuals with COPD. The prevalence of depression in COPD patients is higher than that of anxiety;24 therefore, the prevalence of anxiety was used to estimate the number of participants needed. The prevalence of anxiety in COPD patients was set at 10%;24 therefore, a single clinic needs at least 190 patients; considering the exclusion criteria and potential refusal of participants, each clinic requires at least 240 patients to screen out 19 patients who meet the inclusion criteria. There are 123 clinics with registered COPD cases at least 240 in Xuzhou city. The clinics were sorted in alphabetical order according to Chinese phonetic symbols, from 001 to 123, and 18 clinics were randomly selected using a random number table. Psychological status and severity were assessed for all patients with COPD in selected clinics. All outcome evaluators were blinded to each participant’s grouping and research objectives to minimize bias. Participants Patients were enrolled if they met the 2017 Global Initiative for Chronic Obstructive Lung Disease(GOLD) guidelines (post-bronchodilator FEV₁/FVC < 70%)25 and if they volunteered to participate in the study and signed the informed consent form. The inclusion criteria were as follows: (1) age range 40 to 75 years, regardless of sex; (2) a confirmed diagnosis of COPD classified as GOLD stages I–IV according to the 2017 GOLD guidelines; (3) in the stable phase of COPD, with no respiratory infections or acute exacerbations of COPD in the past 4 weeks; (4) anxiety or depression score ≥ 8 points; and (5) good communication and ability to cooperate in completing all visits, management, and evaluations. The exclusion criteria were as follows: asthma, active tuberculosis, bronchiectasis, lung cancer or malignancy, congestive heart failure, unstable angina pectoris or myocardial infarction within 12 months before enrollment; epilepsy within 12 months before enrollment or epileptic seizures; chronic liver and kidney disease; glaucoma; participation in any other clinical studies in the past 6 months; bipolar depression or other serious psychological disorders; or receiving antidepressant and anxiety medication treatment or other behavioral therapies that may affect psychological changes. The endpoint was the final follow-up result of each participant. The participants were lost to follow-up if they lost contact, refused to communicate or could not complete the visit because of the aggravation of the disease. The criteria for stopping and exiting intervention were (1) intervention-related adverse events; (2) having another serious illness that needs to be treated; (3) suffering severe exacerbation; and (4) receiving other psychotherapy or pulmonary rehabilitation programs. Intervention UC group (usual care): Participants in the UC group received usual care from village doctors based on the patients’ individual needs. The village doctors conducted face‒to-face follow-up with patients every two months to record relevant information and then reported the patient’s health status to our study group. If the patient’s condition deteriorated during the follow-up period, the village doctor provided a diagnosis and treatment or referred them to respiratory experts based on the patient’s condition. CBT group (CBT + UC): A total of 27 village doctors (nurses) [9 from community health service centers and 18 from the village clinic (community health service station)] participated in 3 days of CBT skills training. The training content was developed based on previous studies, including the generation of negative psychology, cognitive intervention, relaxation training, behavior correction, and prevention of recurrence10–16. The Cognitive First Aid Rating Scale (CFARS)26 was used to evaluate the ability of general practitioners to master CBT, with scores ranging from 0 to 6. Higher scores indicate better skills and abilities. A CFARS score of ≥ 4 indicates professional proficiency. After training, CBT was delivered in addition to usual care within the CBT group. All participants were informed of the aim of the study before the intervention, and they were informed that they could withdraw from the study at any time. Our research group formulated a detailed lesson plan for each class and required village doctors to explain according to the lesson plan for at least 45 min. Each group of approximately 10 people participated in activities twice a week. Before each activity, the village doctors notified everyone of the start time and determined whether each patient could participate in the activity. Eight activities are shown in Table 1. All activities were recommended to be completed within one month, and patients were encouraged once more in the second month. Table 1CBT contents and requirements taught to participants.ClassesLearning contentsHomeworkLesson 1Introduced therapeutic process to patients, and made patients to understand the definition, etiology, medication and rehabilitation of COPD, concepts and symptoms of anxiety and depression, as well as their relationship with COPD.Analyzing the causes of one’s own COPD, its impact on one’s own life, and what is one’s understanding of prognosisLesson 2To understand the concept, intervention process, and intervention objectives of cognitive behavioral therapy; The relationship between thinking, feeling, and behavior, ways of incorrect thinking and wrong cognition, and the reasons for their occurrence.What was the current understanding of COPD, what was wrong, and what was correct?Lesson 3Assessed the anxiety and depression symptoms of each patient, helping them analyze the causes of these symptoms and find solutions to itAnalyzed the reasons for one’s symptoms of anxiety and depressionLesson 4Identified negative cognition and thinking. Helping patients understand and recognize irrational cognition and unreasonable automatic thinking that lead to anxiety and depression. Such as: It’s really unlucky, why did I get COPD? Having COPD, I wouldn’t have a good life for the rest of my lifeWhat negative perceptions and thoughts did you have?Lesson 5Reconstructing cognitive patterns. Reconstruct a cognitive model based on reality that is conducive to problem-solving.“Some things were not as bad as I imagined, but rather a bit troublesome.”“I cannot influence others’ opinions for me, the most important thing is that I like myself”’.Had you been able to actively face various problems and pressures caused by COPD in life without generating negative emotionsLesson 6Relieved physical symptoms and cope with stress. Teach patients to pursed lip breathing, improving their respiratory function. Inhale normally through the nose while silently counting 1 and 2, and then exhale through the mouth. Note that when exhaling, the mouth shape should be like a whistle, while making a “exhale~” sound, and try to exhale all the gas in the alveoli as much as possibleLearn to purse lip breathing, once for 15 min, and persist in doing it three times a dayLesson 7Introduce the patient to pranayama, progressive muscle relaxation, and meditation. The doctor first demonstrates, and then the patient exercises under the guidance of the doctorLearn these three relaxation methods, practice no less than 2 times per day, each time for about 30 min, and keep recordsLesson 8Review all activities, collect patient questions and answer them. If there are any questions that cannot be answered, the research group would answer them over the phone. Tell patients to be mentally prepared to deal with symptoms that have not been improved, and discuss ways to deal with recurrence.Establish a contact list. After the curriculum completion, keep in touch with the village doctor in order to receive help and support from the village doctor at any time. Table 1CBT contents and requirements taught to participants.ClassesLearning contentsHomeworkLesson 1Introduced therapeutic process to patients, and made patients to understand the definition, etiology, medication and rehabilitation of COPD, concepts and symptoms of anxiety and depression, as well as their relationship with COPD.Analyzing the causes of one’s own COPD, its impact on one’s own life, and what is one’s understanding of prognosisLesson 2To understand the concept, intervention process, and intervention objectives of cognitive behavioral therapy; The relationship between thinking, feeling, and behavior, ways of incorrect thinking and wrong cognition, and the reasons for their occurrence.What was the current understanding of COPD, what was wrong, and what was correct?Lesson 3Assessed the anxiety and depression symptoms of each patient, helping them analyze the causes of these symptoms and find solutions to itAnalyzed the reasons for one’s symptoms of anxiety and depressionLesson 4Identified negative cognition and thinking. Helping patients understand and recognize irrational cognition and unreasonable automatic thinking that lead to anxiety and depression. Such as: It’s really unlucky, why did I get COPD? Having COPD, I wouldn’t have a good life for the rest of my lifeWhat negative perceptions and thoughts did you have?Lesson 5Reconstructing cognitive patterns. Reconstruct a cognitive model based on reality that is conducive to problem-solving.“Some things were not as bad as I imagined, but rather a bit troublesome.”“I cannot influence others’ opinions for me, the most important thing is that I like myself”’.Had you been able to actively face various problems and pressures caused by COPD in life without generating negative emotionsLesson 6Relieved physical symptoms and cope with stress. Teach patients to pursed lip breathing, improving their respiratory function. Inhale normally through the nose while silently counting 1 and 2, and then exhale through the mouth. Note that when exhaling, the mouth shape should be like a whistle, while making a “exhale~” sound, and try to exhale all the gas in the alveoli as much as possibleLearn to purse lip breathing, once for 15 min, and persist in doing it three times a dayLesson 7Introduce the patient to pranayama, progressive muscle relaxation, and meditation. The doctor first demonstrates, and then the patient exercises under the guidance of the doctorLearn these three relaxation methods, practice no less than 2 times per day, each time for about 30 min, and keep recordsLesson 8Review all activities, collect patient questions and answer them. If there are any questions that cannot be answered, the research group would answer them over the phone. Tell patients to be mentally prepared to deal with symptoms that have not been improved, and discuss ways to deal with recurrence.Establish a contact list. After the curriculum completion, keep in touch with the village doctor in order to receive help and support from the village doctor at any time. CBT contents and requirements taught to participants. Outcomes Primary outcome: The primary outcome was changes in the psychological status, as measured by the Chinese version of the Hospital Anxiety and Depression Scale (HADS). The HADS is a simple and widely used self-assessment scale that consists of two subscales: the HADS-A is used to evaluate anxiety, and the HADS-D is used to evaluate depression. Each subscale has 7 items, with a score range of 0–21 points. Scores ≥ 8 indicate possible anxiety or depression symptoms27. The Cronbach alpha coefficients of the Chinese versions of the HADS-A and HADS-D subscales are 0.753 and 0.764, respectively28. The secondary outcomes included quality of life, dyspnea and pulmonary function. The quality of life was assessed by the St. George’s Respiratory Questionnaire (SGRQ)29. Higher scores indicate a worse quality of life. The SGRQ includes 54 items that evaluate patients’ symptoms, daily activities, and impacts on their social and psychological activities separately. Each item has a corresponding weight, and the final score is determined by calculating the ratio of the sum of positive item weights to the total weight multiplied by 100. Dyspnea was measured using the modified British Medical Research Council (mMRC) dyspnea scale. Each item is scored on a scale ranging from 0 to 4 points, and higher score indicate more difficulty with breathing30. Spirometry was measured using a portable spirometer (Medikro PRO, Finland) at health centers. The participants were asked whether they met the exclusion criteria for the pulmonary function test before the test. Lung function was expressed as the forced expiratory volume in 1s as a percentage of the predicted value [FEV1 (% pred)], with lower values indicating more severe airway obstruction. Other demographic variables We measured participants’ characteristics and general information, including age, sex, education level, drinking and smoking history, comorbidities, duration of disease, GOLD stage, respiratory medication and body mass index (BMI). BMI was calculated by dividing the weight in kilograms by the height in meters squared. All other assessments were conducted in a face-to-face manner by the investigators of our research team. Sample size According to a two-level cluster random design, a total of 2 N communities were selected and randomly assigned to an intervention or control group. The probability of Type I error was 0.05, and the test power was 0.8. A total of 20 subjects were included in each village clinic. Based on previous reports13,14 we assumed that (µ1-µ2) = 2.0 would be a meaningful difference in depression scores between the two groups after the intervention. The total variance wasσ2 = 9, and the intragroup correlation coefficient was ρ = 0.2, which was calculated according to the following formula: n = 2(Z1−α/2+Z1−β)2σ2[1 + (n − 1)ρ]/(µ1 - µ0)2. We concluded that each group needed at least 9 communities and approximately 170 cases, which means that there had to be 19 cases from each community. After accounting for an estimated 10% drop-out rate, we calculated that each group would require at least 187 patients. Ethical considerations This study was carried out according to the protocols approved by Xuzhou Center for Disease Control and Prevention and approved by the Xuzhou Medical Science Ethics Committee (approval number: XYFY2023-KL221-01). The study was conducted in accordance with Chinese national regulations and the Declaration of Helsinki (1975, revised 2008). All participants in the study has been informed about the objective of the trial, and provided written informed consent, and provided all required information before enrolment. The trial was registered with the Chinese Clinical Trials Registry (reference: ChiCTR-TRC-12001958) (22/02/2012). The Consolidated Standards of Reporting Trials (CONSORT) extension for cluster trial guidelines31 was followed in this study. Randomization and masking After the anxiety and depression of the participants were evaluated, a statistician who did not participate in the intervention ranked the 18 village clinics in descending order based on depression scores and number of participants and divided the 18 village clinics into the CBT group (receiving CBT plus UC) and the UC group (receiving UC only) at a 1:1 ratio using a random number table. All the investigators and data analysts were blinded to the group allocations. The participants were recruited by research team members and general practitioners. The health practitioners were responsible for notifying and convening the recruited members, and our team members were responsible for explaining the instructions to the participants and obtaining informed consent. The investigators and statisticians were blinded to the group allocations. Allocation concealment The village clinics were determined by an independent researcher. To ensure concealment before clinic identification, the generated random allocation sequence of village clinics was placed in sequentially encoded, sealed, opaque envelopes and locked in the researcher’s drawer. When the numbered envelope was opened, the clinic was automatically included in the study, and the number on each envelope ensured that all clinics were registered after random allocation. Statistical analysis EpiData 3.1(The EpiData Association, Odense, Denmark) was used to input and manage the data. Statistical analysis was carried out using SPSS 17.0 statistical software. The quantitative data are expressed as the number of cases (percentages), and the comparisons between groups were performed via the χ2 test. The qualitative data are expressed as the means ± standard deviations (xˉ ± s). The data were analyzed using parametric or nonparametric tests, depending on whether the data were normally distributed. A paired t test was used for comparisons between or within groups. The threshold for statistical significance was set at p = 0.05. Repeated-measures analysis of variance was used to examine within-group variation before and after the intervention (time×group interaction effect).All analyses were performed using the intention-to-treat approach. Results Study population In this study,4351 patients who were registered at18 village clinics met the 2017 GOLD criteria. A total of 416 patients declined to participate, and 497 patients did not meet the inclusion criteria. A total of 2975 participants scored < 8 points on the Hospital Anxiety and Depression Scale (HADS).Among the 463 patients with HADS scores ≥ 8, 20 refused to participate in this study. Therefore, ultimately, 443 participants were enrolled in our study. A total of 220 participants from nine clinics were randomly allocated to receive CBT plus usual care, and 223 participants from nine clinics were randomly allocated to receive usual care. There were no significant differences in general characteristics between the two groups at baseline (Table 2). After 6 months of follow-up, there were 392 completers and 51 noncompleters (17 in the CBT group and 34 in the control group), and there was no statistically significant difference in follow-up rates between the two groups (χ2 = 0.003, P = 0 960). No participants received other nondrug treatments during the 2-month follow-up. Figure 1 shows the CONSORT diagram for cluster trials. Fig. 1Participant flow diagram according to the CONSORT extension for cluster trials. Participant flow diagram according to the CONSORT extension for cluster trials. Table 2Comparison of general characteristics of the COPD patients between intervention and control groups at baseline.VariablesCBTUCt/χ2 value P Participant number(n)220223------Age (year)62.01(11.81)63.68(12.54)1.4430.150GenderMale(n,%)107(48.64)108(48.43)0.0020.965Years of Education9.96(3.33)9.68(3.94)0.8070.420Drinking (n, %)55(25.00)57(25.56)0.0180.892Smoking (n, %)33(15.00)39(17.49)0.5040.478Comorbidities(n,%)102(46.36)100(44.84)0.1030.748Duration of disease(year)13.25 ± 6.3112.99 ± 6.020.4440.657BMI(Kg/m2)22.38 ± 4.3422.27 ± 4.280.2690.788GOLD stage(n,%)0.4720.925Ⅰ104(47.27)102(45.74)Ⅱ76(34.55)80(35.87)Ⅲ26(11.82)24(10.76)Ⅳ14(6.36)17(7.62)Respiratory medication (n, %)0.1910.909Long-acting β-agonist12(5.45)11(4.93)Inhaled corticosteroid39(17.73)41(18.38)Chronic systemic corticosteroid63(28.64)70(31.39)Note: Data presented as mean ± SD or number unless otherwise indicated.Abbreviations: COPD=chronic obstructive pulmonary disease;CBT: cognitive behavioral therapy; UC, usualcare.BMI, body mass index; GOLD: GlobalInitiative for Chronic Obstructive Lung Disease.at-test. bChi-square Table 2Comparison of general characteristics of the COPD patients between intervention and control groups at baseline.VariablesCBTUCt/χ2 value P Participant number(n)220223------Age (year)62.01(11.81)63.68(12.54)1.4430.150GenderMale(n,%)107(48.64)108(48.43)0.0020.965Years of Education9.96(3.33)9.68(3.94)0.8070.420Drinking (n, %)55(25.00)57(25.56)0.0180.892Smoking (n, %)33(15.00)39(17.49)0.5040.478Comorbidities(n,%)102(46.36)100(44.84)0.1030.748Duration of disease(year)13.25 ± 6.3112.99 ± 6.020.4440.657BMI(Kg/m2)22.38 ± 4.3422.27 ± 4.280.2690.788GOLD stage(n,%)0.4720.925Ⅰ104(47.27)102(45.74)Ⅱ76(34.55)80(35.87)Ⅲ26(11.82)24(10.76)Ⅳ14(6.36)17(7.62)Respiratory medication (n, %)0.1910.909Long-acting β-agonist12(5.45)11(4.93)Inhaled corticosteroid39(17.73)41(18.38)Chronic systemic corticosteroid63(28.64)70(31.39)Note: Data presented as mean ± SD or number unless otherwise indicated.Abbreviations: COPD=chronic obstructive pulmonary disease;CBT: cognitive behavioral therapy; UC, usualcare.BMI, body mass index; GOLD: GlobalInitiative for Chronic Obstructive Lung Disease.at-test. bChi-square Comparison of general characteristics of the COPD patients between intervention and control groups at baseline. Note: Data presented as mean ± SD or number unless otherwise indicated. Abbreviations: COPD=chronic obstructive pulmonary disease;CBT: cognitive behavioral therapy; UC, usualcare.BMI, body mass index; GOLD: GlobalInitiative for Chronic Obstructive Lung Disease. at-test. bChi-square Village doctors’ competency and CBT participants’ attendance The average competency score for general practitioners was 5.5 ± 0.3, and each of them had scores ≥ 4. Village doctors scored highly in terms of CBT focus/structure therapeutic relationships and patient feedback. A total of 98.7% of the subjects attended all 11 CBT lectures. The participation rates for daily deep breathing, aerobic exercise, progressive muscle relaxation and mindfulness relaxation were 96.5%, 95.4%, 94.1% and 93.8%, respectively. Changes in HADS-D scores At baseline, there was no statistically significant difference in HADS-D scores between the CBT and UC groups (9.94 ± 3.52 vs. 10.12 ± 3.55, t = 0.491; P = 0.624).The mean HADS-D score of the CBT group was 2.32 points lower than that of the UC group after the 6-month intervention (95% CI: 0.90–3.41, P < 0.001)(see Table 3). Table 3Comparison of HADS-D, HADS-A, SGRQ, mMRC scores and FEV1 values between the TBM and UC groups.VariablesBaseline6 monthsInteraction effect estimationCBTUCCBTUCGroupTimeGroup*TimeHADS-D Scores9.94(3.52)10.12(3.55)7.87(3.73)10.20(3.85)12.605/<0.001206.545/<0.001243.296/<0.001HADS-A Scores10.14(3.66)10.39(3.79)8.23(3.60)10.71(4.01)14.419/<0.00187.276/<0.001172.614/<0.001SGRQ scores57.65(24.63)56.88(24.35)41.78(21.56)57.47(24.64)17.518/<0.00194.976/<0.001103.572/<0.001MMRC scores2.25(1.10)2.31(1.20)1.55(0.82)2.32(1.21)8.376/<0.00143.463/<0.00152.857/<0.001FEV1 (% pred)51.21(12.62)51.68(12.49)51.70(12.74)52.02(12.84)0.454/0.5032.316/0.1281.448/0.229Note: Data arepresented as mean ± SD.CBT, cognitive behavioral therapy; UC, usual care; HADS, Hospital Anxiety and Depression Scale; HADS-A, HADS-anxiety; HADS-D, HADS-depression; SGRQ,St. George’s Respiratory Questionnaire; MMRC, Modified British Medical Research Council scale; FEV1, forced expiratory volume in 1s.The results of interaction effect estimation were adjusted for the baseline values of the outcome measures including age, sex, educational level and hospitalized for COPD in the past. Table 3Comparison of HADS-D, HADS-A, SGRQ, mMRC scores and FEV1 values between the TBM and UC groups.VariablesBaseline6 monthsInteraction effect estimationCBTUCCBTUCGroupTimeGroup*TimeHADS-D Scores9.94(3.52)10.12(3.55)7.87(3.73)10.20(3.85)12.605/<0.001206.545/<0.001243.296/<0.001HADS-A Scores10.14(3.66)10.39(3.79)8.23(3.60)10.71(4.01)14.419/<0.00187.276/<0.001172.614/<0.001SGRQ scores57.65(24.63)56.88(24.35)41.78(21.56)57.47(24.64)17.518/<0.00194.976/<0.001103.572/<0.001MMRC scores2.25(1.10)2.31(1.20)1.55(0.82)2.32(1.21)8.376/<0.00143.463/<0.00152.857/<0.001FEV1 (% pred)51.21(12.62)51.68(12.49)51.70(12.74)52.02(12.84)0.454/0.5032.316/0.1281.448/0.229Note: Data arepresented as mean ± SD.CBT, cognitive behavioral therapy; UC, usual care; HADS, Hospital Anxiety and Depression Scale; HADS-A, HADS-anxiety; HADS-D, HADS-depression; SGRQ,St. George’s Respiratory Questionnaire; MMRC, Modified British Medical Research Council scale; FEV1, forced expiratory volume in 1s.The results of interaction effect estimation were adjusted for the baseline values of the outcome measures including age, sex, educational level and hospitalized for COPD in the past. Comparison of HADS-D, HADS-A, SGRQ, mMRC scores and FEV1 values between the TBM and UC groups. Note: Data arepresented as mean ± SD.CBT, cognitive behavioral therapy; UC, usual care; HADS, Hospital Anxiety and Depression Scale; HADS-A, HADS-anxiety; HADS-D, HADS-depression; SGRQ,St. George’s Respiratory Questionnaire; MMRC, Modified British Medical Research Council scale; FEV1, forced expiratory volume in 1s.The results of interaction effect estimation were adjusted for the baseline values of the outcome measures including age, sex, educational level and hospitalized for COPD in the past. Changes in HADS-A scores At baseline, the HADS-A score was10.14 ± 3.66 points in the CBT group and 10.39 ± 3.79 points in the UC group. There was no statistically significant difference in the HADS-A score between the CBT and UC groups (t = 0.697,P = 0.486).The mean HADS-A score of the CBT group was 2.48 points lower than that of the UC group after the 6-month intervention (95% CI: 0.96–4.48, P < 0.001) (see Table 3). Changes in SGRQ scores There were no statistically significant differences in the mean SGRQ score between the CBT and control groups at baseline(57.65 ± 24.63 vs. 56.88 ± 24.35,t = 0.311, P = 0.756). The mean SGRQ score of the CBT group was 15.69 points lower than that of the UC group after the 6-month intervention (95% CI: 11.81–20.32, P < 0.001) (see Table 3). Changes in mMRC scores There was no statistically significant difference in the mean mMRC score between the CBT and UC groups at baseline (t = -0.516, P = 0.606). The mMRC score of the CBT group was 0.76 points lower than that of the UC group at the 6-month follow-up (95% CI: 0.43–0.95, P < 0.001) (see Table 3). Post intervention changes in lung function At baseline, there was no significant difference in the mean FEV1 (% pred) values between the two groups (t = -0.334, p = 0.731), and there was still no significant difference in the mean FEV1 (% pred) values between the two groups after the 6-month intervention (t = -0.454, p = 0.503) (Table 3). Adverse events There were no adverse events related to the CBT intervention or study procedures at the 6-month follow-up. Discussion The main aim of the present study was to determine the feasibility and efficiency of village doctor-led CBT for the management of stable COPD. The results showed that village doctors can be trained to deliver CBT for the management of COPD. This community-based cluster randomized controlled study in China revealed improvements in the psychological status, quality of life and dyspnea of patients with COPD. Evidence on village doctor–delivered CBT specifically for COPD has been very limited. Our findings support the feasibility of village doctor–delivered CBT in community practice and demonstrate its benefits for psychological outcomes in patients with COPD. Patients with exacerbating COPD require treatment, and patients with stable COPD also require pulmonary rehabilitation management. Relying solely on professional institutions and secondary and above medical institutions cannot meet this demand. China has shown improvements in respiratory disease prevention and control capabilities among grassroots-level doctors, indicating that grassroots-level doctors are important for preventing and controlling COPD32. Previous studies have suggested adding CBT to community-based pulmonary rehabilitation for COPD patients33. Chinese scholars have also suggested adding CBT to interventions against anxiety and depression symptoms in the nonpharmacological management of patients with stable COPD34. Some studies have shown that trained community general practitioners or healthcare providers can master CBT methods and successfully implement them22,23. In this trial, 85% of the participants participated in all CBT courses, village doctors were able to accept the content of CBT, and the credibility of teaching patients reached 86.7%.The anxiety and depression symptoms and quality of life of patients with stable COPD improved after the addition of the CBT intervention. Therefore, our results also support the feasibility and acceptability of CBT delivered by community village doctors to manage psychological disorders among patients with stable COPD. Previous studies examining the use of CBT interventions to improve anxiety and depression symptoms have yielded inconsistent results. Our results showed that CBT interventions provided by community doctors could alleviate anxiety and depression symptoms in patients with stable COPD. Four meta-analyses and systematic reviews have shown that CBT can improve depression and anxiety among patients with COPD8,9,17,18. The results of some studies revealed no difference between the control group and CBT group when the HADS was used to evaluate anxiety and depression16,35. This difference may be due to the fact that the intervention hours, intensity, and duration were significantly shorter than those studies than in the current study. Doyle et al.12 conducted eight weekly telephone interventions of CBT in 54 COPD patients, and the results showed that CBT could improve depressive symptoms but not anxiety symptoms, possibly because the effectiveness of telephone intervention was lower than that of face-to-face intervention. When intensity dyads were considered, significant improvements were evident only when high-intensity CBT interventions were compared with enhanced usual care8. Subgroup analysis revealed that an intervention duration of ≥ 8 weeks significantly improved anxiety, whereas an intervention duration of < 8 weeks significantly improved depression17. The CBT intervention provided by community doctors could improve dyspnea in COPD patients, which is consistent with the findings of previous studies13,14,36. Livermore et al.37 implemented CBT treatment once a week for 1 h each time in 18 COPD patients with dyspnea. The results revealed a significant improvement in dyspnea after 6 months. A critical review reported that CBT reduced dyspnea symptoms among patients with COPD37. Dyspnea and depression seem to be interrelated through a variety of different and complex pathways in COPD patients38. CBT could improve the depressive symptoms of COPD patients; therefore, the improvement in depression also led to improvements in dyspnea. Previous studies examining the improvement of quality of life among COPD patients who received CBT have yielded inconsistent results. The participants attended a total of 7 weekly 2-h group sessions, and no significant changes in health status assessed via the SGRQ were observed in the CBT groups11,16. Two studies reported that there were no statistically significant differences in CAT scores before and after the CBT intervention12,38. Systematic reviews and other studies have demonstrated that CBT can improve the quality of life of COPD patients,8–10,17,18 which is consistent with our findings. CBT intervention can reduce dyspnea and alleviate depression and anxiety symptoms, both of which are related to the quality of life of COPD patients. Therefore, CBT could increase the quality of life of COPD patients. From a systematic review and meta-analysis, six studies including 823 participants reported that the FEV1% was greater in the CBT group than in the control group9. Our results showed that CBT could not improve the lung function of patients with COPD, which is inconsistent with the above results9. The authors reported that the results may have publication bias, and it is speculated that the reason may be related to the inclusion of positive study results with a small sample size and unpublished negative study results9. The strengths of this study include the following: first, the trial used a community-based, two-level, multicenter, randomized controlled design. Additionally, the use of a sufficient sample size for the intention-to-treat analysis decreased the risk of bias. This study was conducted by village doctors in the community to intervene with GCBT in COPD patients. Although the professional level of village doctors might not reach the level of professionals, this study strengthened the CBT intervention by another month after completing two months of CBT intervention, which might have resulted in the CBT intervention effects reaching the level of professional intervention, as the intervention intensity affects the effects of CBT intervention8. On the other hand, after mastering CBT skills, village doctors can use them in their daily work, thus providing a skill to support the pulmonary rehabilitation of community-dwelling COPD patients. This study also had several limitations. First, subjective biases may have influenced the results because the participants and village doctors could not be blinded. Second, given the use of self-report questionnaires to assess anxiety and depression, quality of life, and dyspnea, the possibility of incorrect and biased responses cannot be ignored. Third, all the participants were Chinese, and Chinese individuals often consider village doctors to be primary healthcare doctors. Therefore, careful generalization of the results to non-Chinese COPD patients and other countries is necessary. In addition, comorbidity-specific subgroup analyses were not performed because the study’s primary objective and statistical power did not support reliable evaluation by individual comorbidity type. Finally, the six-month follow-up allows assessment only of the short-term effects of CBT. Whether these improvements are maintained over a longer period is unknown, and longer-term studies are needed to determine the durability of village doctor-delivered CBT in COPD. Conclusions In conclusion, village doctors can learn and implement CBT. CBT improved quality of life, reduced anxiety and depression symptoms, and relieved dyspnea in COPD patients. Despite several study limitations, we believe that our results have important implications for public health. These findings suggest that village doctor-delivered CBT may be a feasible and beneficial approach for managing psychological symptoms in patients with COPD. In China, there are approximately 99.9 million COPD patients;24,40 moreover, COPD patients have extremely low treatment rates of psychological symptoms, and village doctors lack the means to treat COPD patients40,41. Therefore, CBT may serve as a useful strategy for village doctors to support the management of COPD patients in community settings.